Surya Pharmaceutical (Delisted) share news and announcements

BSE: 532516

Last traded ₹0.15 on 14 Sep 2015

Delisted on 11 May 2018.

Surya Pharmaceutical share news and announcements

400 announcements, routine notices left out, newest first. Page 3 of 8.

Aug 2012
- 18 Aug · Disclosure
  Vide its letter dated August 14, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 17 Aug · Meeting
  Register of Members & Share Transfer Books of the Company will remain closed from September 27, 2012 to September 29, 2012 for the purpose ....
- 16 Aug · Disclosure
  Surya Pharmaceutical Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 16 Aug · Disclosure
  Surya Pharmaceutical Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 14 Aug · Results
  Financial Results & a copy of the Limited Review Report for the period ended June 30, 2012. (opens in a new tab)
- 14 Aug · Results
  Standalone Financial Results for the period ended June 30,2012. (opens in a new tab)
- 14 Aug · Disclosure
  Alka Goyal,Rajiv Goyal & Emm Bee Fincap Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 9 Aug · Disclosure
  Vide letter dated August 08, 2012 a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 9 Aug · Disclosure
  Alka Goyal has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 9 Aug · Disclosure
  Surya Pharmaceutical Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 7 Aug · Disclosure
  Vide letter dated August 06, 2012 a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 7 Aug · Disclosure
  Alka Goyal has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 7 Aug · Disclosure
  Surya Pharmaceutical Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 6 Aug · Board meeting
  Inter alia, to consider the followings :- (1) To take on record the un-audited Financial Results (Provisional) of the Company for the quarter ended June 30, 2012.(2) To consider and approve Book Closure of Register of Members and Share Transfer Books of the Company for the purpose of Annual General Meeting.
- 3 Aug · Disclosure
  Alka Goyal has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 3 Aug · Disclosure
  Surya Pharmaceutical Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 3 Aug · Disclosure
  Vide letter dated August 02, 2012 a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
Jul 2012
- 31 Jul · Disclosure
  Vide letter dated July 30, 2012 a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 31 Jul · Disclosure
  Surya Pharmaceutical Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 31 Jul · Disclosure
  Alka Goyal has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 30 Jul · Disclosure
  Vide letter dated July 27, 2012 a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 27 Jul · Disclosure
  Alka Goyal has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 27 Jul · Disclosure
  Surya Pharmaceutical Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 24 Jul · Disclosure
  Vide letter dated July 20, 2012 a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 20 Jul · Disclosure
  Alka Goyal has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 20 Jul · Disclosure
  Surya Pharmaceutical Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 17 Jul · Disclosure
  Alka Goyal has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 17 Jul · Disclosure
  Surya Pharmaceutical Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 17 Jul · Disclosure
  Vide letter dated July 17, 2012 a copy of Disclosure pursuant to Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 17 Jul · Disclosure
  Vide letter dated July 16, 2012 a copy of Disclosure pursuant to Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 16 Jul · Disclosure
  Alka Goyal has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 16 Jul · Disclosure
  Surya Pharmaceutical Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 12 Jul · Disclosure
  Vide letter dated July 12, 2012 a copy of Disclosure pursuant to Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 12 Jul · Disclosure
  Alka Goyal has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 12 Jul · Disclosure
  Surya Pharmaceutical Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 12 Jul · Disclosure
  Vide letter dated July 10, 2012 a copy of Disclosure pursuant to Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 11 Jul · Disclosure
  Alka Goyal has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 11 Jul · Disclosure
  Surya Pharmaceutical Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 10 Jul · Results
  Standalone Financial Results for the period ended March 31,2012. (opens in a new tab)
- 10 Jul · Results
  Audited Financial Results for the period ended March 31, 2012. (opens in a new tab)
- 9 Jul · Disclosure
  Alka Goyal has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 9 Jul · Disclosure
  Surya Pharmaceutical Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 9 Jul · Management
  1. The Board has appointed Mr. Bharat Bhushan Jain as Company Secretary & Compliance officer of the Company in place of Mrs. Sugandha ....
- 9 Jul · Board meeting
  Board of Directors of the Company held on July 07, 2012 approved the following: (1) The Board has appointed Mr. Bharat Bhushan Jain as Company Secretary & Compliance officer of the Company in place of Mrs. Sugandha Kukreja w.e.f. June 16, 2012.(2) Further, Mr. Sanjay Kumar Suroya, Nominee Director of IDBI has resigned from the Directorship of the Company w.e.f. July 05, 2012.
- 9 Jul · Disclosure
  Vide letter dated July 06, 2012 a copy of Disclosure pursuant to Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 5 Jul · Disclosure
  Vide letter dated July 03, 2012 a copy of Disclosure pursuant to Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 4 Jul · Disclosure
  Surya Pharmaceutical Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 4 Jul · Disclosure
  Alka Goyal has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 3 Jul · Disclosure
  Vide letter dated July 02, 2012 a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 2 Jul · Disclosure
  Rajiv Goyal has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)